Multicentre Evaluation of IL Test™ Free PS: A Fully Automated Assay to Quantify Free Protein S

Summary

Deficiency of the anticoagulant vitamin K-dependent protein S (PS) is associated with increased risk of venous thrombosis. In human plasma, PS circulates in two forms: as free protein (free PS) and PS bound to C4b-binding protein (C4BP), a regulator of the complement system. Assays for free PS have higher sensitivity and specificity for protein S deficiency than assays for total protein S. We have extensively evaluated the analytical performance of a novel assay for free PS, the IL Test™ Free Protein S, which takes advantage of the affinity of C4BP for free PS, and compared its performance to existing methods. IL Test™ Free Protein S is a rapid, fully automated turbidimetric assay consisting of two reagents: a C4BP coated latex and an anti-PS monoclonal antibody coated latex. The test range, precision and linearity were adequate and the assay tolerated high concentrations of interfering substances of clinical significance. The reference range agreed with previously published studies. The analysis of 903 patient samples belonging to 20 different clinical categories with the new assay yielded free PS results that agreed well with those obtained using the assays established in the participating laboratories. The study demonstrated the IL Test™ Free Protein S to be rapid, reliable and easy to perform.

Keywords

Protein S - coagulation inhibitors - thrombosis - thrombophilia

• References

• 1 DiScipio RG, Davie EW. Characterization of protein S, a )’-carboxy-glutamic acid containing protein from bovine and human plasma. Biochemistry 1979; 18: 899-904.
• 2 Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999; 93: 1798-808.
• 3 Walker FJ. Regulation of activated protein C by protein S The role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128-31.
• 4 Dahlbäck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4bbinding protein. Proc Natl Acad Sci 1981; 78: 2512-6.
• 5 Dahlbäck B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
• 6 Dahlbäck B, Stenflo J. A natural anticoagulant pathway: Proteins C, S, C4b-binding protein and thrombomodulin. In: Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. eds. Edinburg: Churchill Livingstone; 1994. Vol 2, 671-98.
• 7 Hillarp A, Dahlbäck B. Novel subunit in C4b-binding protein required for protein S binding. J Biol Chem 1988; 263: 12759-12764.
• 8 Dahlbäck B, Frohm B, Nelsestuen G. High affinity interaction between C4b-binding protein and vitamin K-dependent protein S in the presence of calcium Suggestion of a Third Component in Blood Regulating the Interaction. J Biol Chem 1990; 265: 16082-7.
• 9 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-8.
• 10 Schwarz HP, Fisher M, Hopmeyer P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-300.
• 11 Broekmans AW, van Der Linden IK, Jansen-Koeter Y, Bertina RM. Prevalence of protein C (PC) and protein S (PS) deficiency in patients with thromboembolic disease. Thromb Res Suppl 1986; 06: 135a.
• 12 Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59: 18-22.
• 13 Pabinger I, Brucker S, Kyrle PA, Schneider B, Korninger HC, Niessner H, Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinolysis 1992; 03: 547-53.
• 14 Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2132 consecutive unselected patients with venous thromboembolism Results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997; 77: 441-51.
• 15 Mahasandana C, Suvatte V, Marlar RA, Manco MJJohnson, Jacobson LJ, Hathaway WE. Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 1990; 335: 61-2.
• 16 Takahashi H, Tatewaki W, Wada K, Shibata A. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus and under oral anticoagulant therapy. Clin Chim Acta 1989; 182: 195-208.
• 17 Ginsberg JS, Demers C, Brill-Edwards P, Bona R, Johnston M, Wong A, Denburg JA. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med 1995; 98: 79-383.
• 18 Bertina R. Nomenclature proposal for protein S deficiency. XXXVI Annual meeting of the Scientific and Standardisation Committee of the ISTH. Barcelona (Spain).
• 19 Zöller B, de García PFrutos, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-31.
• 20 Espinosa-Parrilla Y, Morell M, Souto JC, Tirado I, Fontcuberta J, Estivill X, Sala N. Protein S gene analysis reveals the presence of a cosegregating mutation in most pedigrees with Type I but not with Type III deficiency. Hum Mut 1999; 14: 30-9.
• 21 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Nat Acad Sci 1993; 90: 1004-8.
• 22 Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: Interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-71.
• 23 Cooper PC, Hampton KK, Makris M, Abuzenadah A, Paul B, Preston FE. Further evidence that activated protein C resistance can be misdiagnosed as inherited functional protein S deficiency. Br J Haematol 1994; 88: 201-3.
• 24 Woodhams BJ. The simultaneous measurement of total and free protein S by ELISA. Thromb Res 1988; 50: 213-20.
• 25 Amiral J, Grosley B, Boyer-Neumann C, Marfaing-Koka A, Peynaud-Debayle E, Wolf M, Meyer D. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form. Blood Coagul Fibrinolysis 1994; 05: 179-86.
• 26 Giri TS, Hillarp A, Härdig Y, Zöller B, Dahlbäck B. A new direct, fast and quantitative enzyme-linked ligand sorbent assay for measurement of free protein S antigen. Thromb Haemost 1998; 79: 767-72.
• 27 Deffert C, Esteve M, Grimaux M, Gouault-Heilmann M. A direct, automated, immuno-turbidimetric assay of free protein S antigen in plasma. Blood Coagul Fribinolysis 2001; 12: 137-41.
• 28 Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-56.
• 29 Serra J, Puig J, Martín A, Galisteo F, Gálvez MJ, Hidalgo-Álvarez R. On the adsorption of IgG onto polystyrene particles: electrophoretic mobility and critical coagulation concentration. Colloid Polym Sci 1992; 270 (06) 574-83.
• 30 Dahlbäck B, Hildebrand B, Malm J. Characterization of functuonally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265 (14) 8127-35.
• 31 Gella FJ, Serra J, Gener J. Latex agglutination procedures in immunodiagnosis Pure & Appl. Chem 1991; 63 (08) 1131-34.
• 32 Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-8.
• 33 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
• 34 Triplett DA. Lupus Anticoagulant. In: Laboratory Techniques in Thrombosis. A manual. 2nd ed. Jespersen J, Bertina RM, Havercate F. eds. Dordrecht, The Netherlands: Kluwer Academic Publishers BV; 1999
• 35 Preda L, Tripodi A, Valsecchi C, Lombardi A, Finotto E, Mannucci PM. A Prothrombin Time-based functional assay of Protein S. Thromb Res 1990; 60: 19-32.
• 36 Gharavi AE, Harris EN, Asherson RA, Huges GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
• 37 Glick MR, Ryder KW, Jackson SA. Graphical Comparisons of Interference in Clinical Chemistry Instrumentation. Clin Chem 1986; 32/3: 470-5.
• 38 Solberg HE. Approved Recommendation on the Theory of Reference Values Part 5. Statistical Treatment of Collected Reference values. Determination of Reference Limits. J Clin Chem Clin Biochem 1987; 25: 645-56.
• 39 Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709-20.
• 40 Zöller B, Bernsdotter A, de García PFrutos, Dahlbäck B. Resistance to activated protein C as an additional risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-23.
• 41 Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thrombembolic disease – critical evaluation of laboratory investigation. Thromb Haemost 1992; 68: 7-13.
• 42 Faioni EM, Valsecchi C, Palla A, Taioli E, Razzari C, Mannucci PM. Free protein S deficiency is a risk factor for venous thrombosis. Thromb Haemost 1997; 78: 1343-6.
• 43 Shen MC, Lin JS, Tsay W. Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombohilic patients in Taiwan. Thromb Res 2000; 99: 447-52.
• 44 Koster T, Rodendaal FR, Briet E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected out-patients: An infrequent, but clear risk factor for venous thromboembolism (Leiden thrombophilia study). Blood 1995; 85: 2756-61.
• 45 Moerloose PD, Bounameaux HR, Mannucci PM. Screening tests for thrombophilic patients: which tests, for which patient, by whom, when, and why?. Semin Thromb Haemost 1998; 24 (04) 321-7.
• 46 Persson KEM, Hillarp AA, Dahlbäck B. Analytical considerations for free protein S assays in protein S deficiency. Thromb Haemost 2001; 86: 1144-7.
• 47 Henkens CMA, Bom VJJ, van der Schaaf W, Pelsma PM, Sibinga CThS, de Kam PJ, van der Meer J. Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age. Thromb Haemost 1995; 74: 1271-5.
• 48 Liberti G, Bertina RM, Rosendaal F. Hormonal state rather than age influenced the cut-off values of protein S Re-evaluation of the thrombotic risk associated with protein S deficiency in the Leiden Thrombophilia Study. Thromb Haemost 1999; 82: 1093-6.
• 49 Malm J, Laurell M, Dahlbäck B. Changes in the plasma levels of vitamin Kdependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol 1988; 68: 437-43.
• 50 Malm J, Bennhagen R, Holmberg L, Dahlbäck B. Plasma concentrations of C4b-binding protein and vitamin K-dependent protein S in term and preterm infants: low levels of protein S-C4b-binding protein complex. Br J Haematol 1988; 68: 445-9.
• 51 de García PFrutos, Alim RIM, Härdig Y, Zöller B, Dahlbäck B. Differential regulation of a and b chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994; 84: 815-22.